Watchlist Price Alert

Talaris Therapeutics Inc. (TALS)

NASDAQ: TALS · Real-Time Price · USD

2.72

-0.02 (-0.73%)

At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-69.34M	-80.23M	-82.14M	-76.48M	-71.04M	-64.27M	-56.92M	-47.51M	-39.95M	-33.03M	-26.71M	-22.68M	-15.85M	-9.71M	-4.97M
Interest Income	1.76M	1.76M	500.00	500.00	200.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-62.78M	-74.77M	-78.13M	-73.89M	-69.61M	-63.54M	-56.79M	-47.83M	-40.37M	-33.85M	-27.16M	-22.71M	-15.93M	-9.51M	-4.85M
Net Income	-57.66M	-68.84M	-72.2M	-69.54M	-68.8M	-63.54M	-56.79M	-47.83M	-40.37M	-33.85M	-27.16M	-22.71M	-15.93M	-9.51M	-4.85M
Selling & General & Admin	26.51M	22.23M	21.44M	19.47M	18.09M	17.12M	15.38M	13.7M	12.35M	10.66M	8.51M	7.41M	4.96M	2.77M	1.44M
Research & Development	32.41M	47.13M	56.22M	57.01M	52.95M	47.16M	41.54M	33.81M	27.6M	22.38M	18.21M	15.28M	10.89M	6.94M	3.54M
Other Expenses	10.96M	10.87M	4.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	59.01M	69.36M	77.66M	76.48M	71.04M	64.27M	56.92M	47.51M	39.95M	33.03M	26.71M	22.68M	15.85M	9.71M	4.97M
Interest Expense	5.45M	4.35M	2.58M	2.58M	812K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	59.01M	69.36M	77.66M	76.48M	71.04M	64.27M	56.92M	47.51M	39.95M	33.03M	26.71M	22.68M	15.85M	9.71M	4.97M
Income Tax Expense	-499K	-1.31M	-5.93M	-4.35M	-812K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.27M	4.22M	4.18M	4.15M	4.14M	41.09M	40.98M	40.93M	40.67M	27.37M	41.24M	21.19M	21.19M	21.19M	21.19M
Shares Outstanding (Diluted)	4.27M	4.22M	4.18M	4.15M	4.14M	41.09M	40.98M	40.93M	40.67M	27.37M	41.24M	21.19M	21.19M	21.19M	21.19M
EPS (Basic)	-13.74	-16.5	-13.45	-8.9	-5.64	-1.56	-1.53	-1.31	-1.28	-1.26	-1.07	-1.07	-0.75	-0.45	-0.23
EPS (Diluted)	-13.74	-16.5	-13.45	-8.9	-5.64	-1.56	-1.53	-1.31	-1.28	-1.26	-1.07	-1.07	-0.75	-0.45	-0.23
EBITDA	-38.17M	-48.49M	-49.85M	-53.3M	-69.24M	-62.88M	-55.94M	-46.88M	-39.39M	-32.51M	-26.23M	-22.24M	-15.53M	-9.52M	-4.88M
EBIT	-34.83M	-47.93M	-34.96M	-34.96M	-18.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	10.38M	10.98M	11.28M	2.16M	1.8M	1.39M	976K	623K	560K	522K	490K	447K	322K	193K	92K